Lynda Chin

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• A feasibility study of ApricityCarefor early detection and management of immune-related adverse events in cancer patients receiving immune checkpoint therapies.

  Journal of Clinical Oncology · 2026-05-28

• Abstract 4477: Resistance interception: Development of novel immune checkpoint inhibitor as dynamic combination with Anti-PD-1 to overcome resistance.

  Cancer Research · 2026-04-03

• Editor’s Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

  Cancer Discovery · 2025-12-02

• A pilot study of the ApricityCare program for early detection and management of treatment-related adverse events in patients with metastatic cancer.

  Journal of Clinical Oncology · 2025-05-28

• Abstract 5545: Dynamic Precision™: a scalable tech-bio platform to identify immune-mediated resistance through dynamic monitoring

  Cancer Research · 2025-04-21

• Abstract A043: A dynamic approach to functional precision medicine: Developing next-generation immunotherapy to overcome treatment resistance

  Cancer Research · 2025-03-11

• Abstract A100: A dynamic view of adaptive resistance enables the development of precision immune-therapies for people living with cancer

  Cancer Immunology Research · 2025-02-23